首页> 外文期刊>Pattern recognition letters >DPFMDA: Distributed and privatized framework for miRNA-Disease association prediction
【24h】

DPFMDA: Distributed and privatized framework for miRNA-Disease association prediction

机译:DPFMDA:用于miRNA-疾病关联预测的分布式和私有化框架

获取原文
获取原文并翻译 | 示例
       

摘要

In this paper, we developed a novel distributed and privatized framework for miRNA-disease association prediction (DPFMDA) to predict potential miRNA-disease associations. DPFMDA assumes that diseases and miRNAs can be represented as feature matrices. Through independent factorization, collaborative analysis and matrix re-factorization, feature matrices are estimated and potential associations in miRNA-disease association matrix are predicted. The proposed computational model is tested and verified by leave-one-out cross validation (LOOCV). The AUCs of global and local LOOCV are 0.8859 and 0.8267 respectively, which outperform the state-of-the-art computational models. DPFMDA is further evaluated with case studies of four important human complex diseases. We test Esophageal Neoplasms and Prostate Neoplasms using DPFMDA in the HMDD v2.0 database. For Breast Neoplasms, we use the HMDD v2.0 database which removes all the known miRNAs-disease associations on Breast Neoplasms. For Hepatocellular Carcinoma, HMDD v1.0 database is used as the input of DPFMDA and predicted results are verified with HMDD v2.0, dbDEMC and miR2Disease databases. The results show that 90% (Esophageal Neoplasms), 88% (Prostate Neoplasms), 98% (Breast Neoplasms) and 86% (Hepatocellular Carcinoma) of top 50 predicted miRNA-disease associations are confirmed by recent experimental studies respectively. It is anticipated that DPFMDA would be an effective and extensible method for potential miRNA-disease association prediction. (C) 2017 Elsevier B.V. All rights reserved.
机译:在本文中,我们为miRNA疾病关联预测(DPFMDA)开发了一种新颖的分布式私有化框架,以预测潜在的miRNA疾病关联。 DPFMDA假定疾病和miRNA可以表示为特征矩阵。通过独立的因子分解,协作分析和矩阵重构,可以估计特征矩阵并预测miRNA-疾病关联矩阵中的潜在关联。所提出的计算模型已通过留一法交叉验证(LOOCV)进行了测试和验证。全局和局部LOOCV的AUC分别为0.8859和0.8267,这优于最新的计算模型。通过对四种重要的人类复杂疾病的案例研究进一步评估了DPFMDA。我们在HMDD v2.0数据库中使用DPFMDA测试食管肿瘤和前列腺肿瘤。对于乳腺肿瘤,我们使用HMDD v2.0数据库,该数据库删除了乳腺肿瘤上所有已知的miRNA-疾病关联。对于肝细胞癌,HMDD v1.0数据库用作DPFMDA的输入,并用HMDD v2.0,dbDEMC和miR2Disease数据库验证了预测结果。结果表明,最近的实验研究分别证实了前50种预测的miRNA-疾病关联中有90%(食道肿瘤),88%(前列腺肿瘤),98%(乳腺肿瘤)和86%(肝细胞癌)。预期DPFMDA将成为潜在的miRNA-疾病关联预测的有效且可扩展的方法。 (C)2017 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号